The Canadian Clinical Drug Data Set April 2025 release is now available for access and implementation on the Terminology Server and Terminology Gateway.
Learn More >
Important Update: We are pleased to announce significant enhancements to our FHIR Terminology Server, offering more seamless and standards-based access to terminology content for healthcare data exchange. Discover the new features and upcoming changes to our Terminology Gateway.
Learn More >
Further to the discussion on Canadian Vital signs there is a Canadian consideration for Growth Charts and percentiles. In Canada we used to use the CDC growth charts until about 10 years ago when we switched to WHO growth charts. I think for the most part, America still uses the CDC charts. Should CHI ask Regenstrief to qualify which growth chart is used to generate the percentiles for their LOINC codes ie - to have separate LOINC codes for the percentiles derived by the two methods CDC and WHO? Then we could recommend the WHO LOINC be used in the Canadian baseline vital signs profiles.
What we’ve reviewed so far at the Clinical substream WG almost fully aligns with FHIR Vital Signs except minor additions (e.g., few optional Must Support elements). Are there other specific reasons to add vital signs profiles to CA Core, e.g., a certain value set to use, etc.?
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.
CA Core vital signs profiles
Print
Email
Twitter